Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria

NCT04853992 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Cholinergic Urticaria

Interventions

DRUG: LEO 152020
DRUG: LEO 152020 placebo

Sponsor

JW Pharmaceutical

Collaborators

[object Object]